166 related articles for article (PubMed ID: 10681359)
1. Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.
Kirkpatrick WR; McAtee RK; Fothergill AW; Loebenberg D; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2000 Mar; 44(3):780-2. PubMed ID: 10681359
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis.
Patterson TF; George D; Ingersoll R; Miniter P; Andriole VT
Antimicrob Agents Chemother; 1991 Oct; 35(10):1985-8. PubMed ID: 1759818
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
Denning DW; Hall L; Jackson M; Hollis S
Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis.
Patterson TF; Fothergill AW; Rinaldi MG
Antimicrob Agents Chemother; 1993 Nov; 37(11):2307-10. PubMed ID: 8285610
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Kirkpatrick WR; McAtee RK; Fothergill AW; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2000 Oct; 44(10):2865-8. PubMed ID: 10991875
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
[TBL] [Abstract][Full Text] [Related]
7. SCH56592 treatment of murine invasive aspergillosis.
Graybill JR; Bocanegra R; Najvar LK; Luther MF; Loebenberg D
J Antimicrob Chemother; 1998 Oct; 42(4):539-42. PubMed ID: 9818757
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
Oakley KL; Morrissey G; Denning DW
Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
[TBL] [Abstract][Full Text] [Related]
9. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Prince RA; Chi J; Kontoyiannis DP
Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
[TBL] [Abstract][Full Text] [Related]
10. Saperconazole therapy in a rabbit model of invasive aspergillosis.
Patterson TF; George D; Miniter P; Andriole VT
Antimicrob Agents Chemother; 1992 Dec; 36(12):2681-5. PubMed ID: 1482137
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Longman LP; Martin MV
J Antimicrob Chemother; 1987 Nov; 20(5):719-24. PubMed ID: 2828301
[TBL] [Abstract][Full Text] [Related]
12. [Progress in combination therapy for invasive aspergillosis].
Luo L; Tong Z
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):41-4. PubMed ID: 24694973
[No Abstract] [Full Text] [Related]
13. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
Chandrasekar PH; Cutright J; Manavathu E
J Antimicrob Chemother; 2000 May; 45(5):673-6. PubMed ID: 10797091
[TBL] [Abstract][Full Text] [Related]
14. In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus.
Dannaoui E; Borel E; Persat F; Monier MF; Piens MA; Network E
J Med Microbiol; 1999 Dec; 48(12):1087-1093. PubMed ID: 10591162
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Perea S; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2002 Aug; 46(8):2564-8. PubMed ID: 12121933
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis.
Verweij PE; Oakley KL; Morrissey J; Morrissey G; Denning DW
Antimicrob Agents Chemother; 1998 Apr; 42(4):873-8. PubMed ID: 9559799
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
18. Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories.
Najvar LK; Cacciapuoti A; Hernandez S; Halpern J; Bocanegra R; Gurnani M; Menzel F; Loebenberg D; Graybill JR
Antimicrob Agents Chemother; 2004 Mar; 48(3):758-64. PubMed ID: 14982761
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.
Dannaoui E; Meletiadis J; Tortorano AM; Symoens F; Nolard N; Viviani MA; Piens MA; Lebeau B; Verweij PE; Grillot R; And The Ebga Network
J Med Microbiol; 2004 Feb; 53(Pt 2):129-134. PubMed ID: 14729934
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]